The FDA has approved Zepbound (tirzepatide) for the treatment of moderate to severe obstructive sleep apnea in adults with ...

These reactions should go away on their own within a few days of injecting your Zepbound dose. But, if you experience a reaction that’s severe or bothersome to you, talk with your doctor.

Patients taking a compounded alternative to Eli Lilly's weight loss drug Zepbound will need to transition to the name-brand ...

Study participants were randomly assigned 1:1 to receive Zepbound (10mg or 15mg; maximum tolerated dose) or placebo injected subcutaneously once weekly. The primary endpoint was the change from ...

Lilly achieved the supply milestone first, with the FDA in early October removing Mounjaro and Zepbound from its online database in a move that ended a 22-month stretch of tirzpetatide dose ...

The decision will largely prevent compounding pharmacies from making and selling compounded versions of the drug in the next ...

The company argued that following a $23 billion manufacturing scale-up campaign, all doses of Mounjaro and Zepbound have been available in the U.S. since August, several months before the shortage ...

This order relates to certain FDA-approved Mounjaro and Zepbound products. The Mounjaro products are pre-filled single-dose pens (2.5 mg/0.5 mL, 5 mg/0.5 mL, 7.5 mg/0.5 mL, 10 mg/0.5 mL ...

Eli Lilly’s weight loss drug Zepbound is no longer in short supply ... as it has received reports of patients giving themselves the incorrect dose of off-brand drugs. "These dosing errors ...